Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Pharmaceuticals
Wilmington PharmaTech plans to spend $18 million to expand a research and manufacturing facility in Newark, Delaware, a project that it says will add 139 jobs at the site. The drug contract research and development organization was launched in 2003 by Hui-Yin “Harry” Li, a former DuPont research chemist. It has three facilities in Newark—one previously owned by DuPont—and employs 37 people in the city. The company also operates a plant in Suzhou, China.
This article has been sent to the following recipient: